Fairvoy Private Wealth’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Fairvoy Private Wealth's DGX Position: Q3 2026 in Review
Fairvoy Private Wealth reduced its Quest Diagnostics (DGX) stake by 6.6% in Q3 2026, selling an estimated $33.5K and leaving 2,044 shares worth $476K. The position accounts for 0.1% of the portfolio, ranked #138.
Fairvoy Private Wealth first reported a position in DGX in Q3 2025 and has held it in 5 quarters since. The position peaked at $518K in Q1 2026. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Fairvoy Private Wealth held 2,044 shares of Quest Diagnostics worth $476K as of Q3 2026.
- Fairvoy Private Wealth sold 145 Quest Diagnostics shares in Q3 2026, an estimated $33.5K.
- Quest Diagnostics made up 0.1% of Fairvoy Private Wealth's portfolio in Q3 2026, its #138 holding.
- Fairvoy Private Wealth first reported a position in Quest Diagnostics in Q3 2025 and has held it in 5 quarters since.
- Fairvoy Private Wealth's Quest Diagnostics position peaked at $518K in Q1 2026.
- 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Fairvoy Private Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.